<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-188-4-76-83</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-1632</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>COVID-19</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>COVID-19</subject></subj-group></article-categories><title-group><article-title>Изменение концентрации аммиака и других биохимических показателей у пациентов с новой коронавирусной инфекцией</article-title><trans-title-group xml:lang="en"><trans-title>Change in concentration of ammonia and other biochemical indicators in patients with new coronaviral infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8736-5851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лазебник</surname><given-names>Л. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazebnik</surname><given-names>L. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лазебник Леонид Борисович, профессор кафедры поликлинической терапии, профессор, доктор медицинских наук</p><p>127994, ГСП-4, г. Москва, Рахмановский пер, 3</p></bio><bio xml:lang="en"><p>Leonid B. Lazebnik, Professor of the Department of Polyclinic Therapy, Professor, Doctor of Medical Sciences</p><p>127994, GSP-4, Moscow, Rakhmanovsky lane, 3</p><p>Scopus ID: 7005446863</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1496-0689</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарасова Лариса Владимировна, заведующая кафедрой факультетской и госпитальной терапии, профессор, доктор медицинских наук</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Larisa V. Tarasova, Head of the department of faculty and hospital therapy, Professor, Doctor of Medical Sciences</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p><p>Scopus ID: 35777248600</p></bio><email xlink:type="simple">tlarisagast18@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комарова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Komarova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Комарова Екатерина Анатольевна, аспирант кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Еkaterina A. Komarova, post-graduate student of the department of faculty and hospital therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8339-9496</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыганова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsyganova</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цыганова Юлия Вадимовна, ассистент кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Yuliya V. Tsyganova, assistant of the department of faculty and hospital therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7313-0365</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бусалаева</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Busalaeva</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бусалаева Елена Исааковна, доцент кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Elena I. Busalaeva, Associate Professor of the Department of Faculty and Hospital Therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p><p>Scopus ID: 56657473200</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8441-9391</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барсукова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Вarsukova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барсукова Елена Владимировна, доцент кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Elena V. Вarsukova, Associate Professor of the Department of Faculty and Hospital Therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1056-0725</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орешникова</surname><given-names>С. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Oreshnikova</surname><given-names>F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орешникова Светлана Федоровна, доцент кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Svetlana F. Oreshnikova, Associate Professor of the Department of Faculty and Hospital Therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1611-0733</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орешников</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Oreshnikov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Орешников Александр Витальевич, ассистент кафедры факультетской и госпитальной терапии</p><p>428015 г. г. Чебоксары, Московский проспект, 45</p></bio><bio xml:lang="en"><p>Aleksandr V. Oreshnikov, Associate Professor of the Department of Faculty and Hospital Therapy</p><p>428015 Russia, Cheboksary, Moskovsky prospect, 45</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Московский государственный медико- стоматологический университет имени А. И. Евдокимова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Moscow State University of Medicine and Dentistry named after A. I. Evdokimov” Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Чувашский государственный университет им. И. Н. Ульянова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Chuvash State University named after I. N. Ulyanov”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>20</day><month>07</month><year>2021</year></pub-date><volume>0</volume><issue>4</issue><fpage>76</fpage><lpage>83</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лазебник Л.Б., Тарасова Л.В., Комарова Е.А., Цыганова Ю.В., Бусалаева Е.И., Барсукова Е.В., Орешникова С.Ф., Орешников А.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Лазебник Л.Б., Тарасова Л.В., Комарова Е.А., Цыганова Ю.В., Бусалаева Е.И., Барсукова Е.В., Орешникова С.Ф., Орешников А.В.</copyright-holder><copyright-holder xml:lang="en">Lazebnik L.B., Tarasova L.V., Komarova E.A., Tsyganova Y.V., Busalaeva E.I., Вarsukova E.V., Орешникова С.Ф., Oreshnikov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/1632">https://www.nogr.org/jour/article/view/1632</self-uri><abstract><p>Статья демонстрирует результаты исследования по изучению сравнительной оценки концентрации аммиака в периферической крови пациентов с вирусной инфекцией COVID-19 на фоне ранее имевшейся печёночной патологии и без неё. Отмечена корреляция гипераммониемии периферической крови и повышении концентрации маркёров острого воспаления. Прослежена связь между высокой степенью гипераммониемии и тяжёлым течением/летальным исходом в результате развития новой коронавирусной инфекции исследуемых пациентов. Выделена роль исходной хронической печёночной патологии (в том числе неалкогольной жировой болезни печени) как фактора неблагоприятного течения новой коронавирусной инфекции.</p></abstract><trans-abstract xml:lang="en"><p>The article demonstrates the results of a study to study the comparative assessment of the concentration of ammonia in the peripheral blood of patients with a viral infection of COVID-19 against the background of previously existing hepatic pathology and without it. There was a correlation between peripheral blood hyperammonemia and an increase in the concentration of markers of acute inflammation. The relationship between a high degree of hyperammonemia and a severe course / death as a result of the development of a new coronavirus infection in the studied patients was traced. The role of the initial chronic hepatic pathology (including non-alcoholic fatty liver disease) as a factor in the unfavorable course of the new coronavirus infection is highlighted.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипераммониемия</kwd><kwd>аммиак периферической крови</kwd><kwd>коронавирусная инфекция</kwd><kwd>COVID-19</kwd><kwd>тяжёлое течение</kwd><kwd>летальный исход</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hyperammonemia</kwd><kwd>peripheral blood ammonia</kwd><kwd>coronavirus infection</kwd><kwd>COVID-19</kwd><kwd>severe course</kwd><kwd>death</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Временные методические рекомендации. Про фи лакти ка, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 10 (08.02.2021).</mixed-citation><mixed-citation xml:lang="en">Temporary guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)”. Version 10 (08.02.2021) (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Xu L., Liu J., Lu M., et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004. doi: 10.1111/liv.14435</mixed-citation><mixed-citation xml:lang="en">Xu L., Liu J., Lu M., et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998–1004. doi: 10.1111/liv.14435</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Young B.E., Ong S. W. X., Kalimuddin S., et al. Epidemio logic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020; 323(15): 1488–94. doi: 10.1001/jama.2020.3204. Erratum in: JAMA. 2020 Apr 21;323(15):1510. PMID: 32125362; PMCID: PMC7054855.</mixed-citation><mixed-citation xml:lang="en">Young B.E., Ong S. W. X., Kalimuddin S., et al. Epidemio logic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020; 323(15): 1488–94. doi: 10.1001/jama.2020.3204. Erratum in: JAMA. 2020 Apr 21;323(15):1510. PMID: 32125362; PMCID: PMC7054855.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. doi:10.1001/jama.2020.6775</mixed-citation><mixed-citation xml:lang="en">Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. doi:10.1001/jama.2020.6775</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal- Oral Transmission. Gastroenterology. 2020 May;158(6):1518–1519. doi: 10.1053/j.gastro.2020.02.054. Epub 2020 Mar 3. PMID: 32142785; PMCID: PMC7130192.</mixed-citation><mixed-citation xml:lang="en">Gu J, Han B, Wang J. COVID-19: Gastrointestinal Manifestations and Potential Fecal- Oral Transmission. Gastroenterology. 2020 May;158(6):1518–1519. doi: 10.1053/j.gastro.2020.02.054. Epub 2020 Mar 3. PMID: 32142785; PMCID: PMC7130192.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">F Del Zompo 1, M De Siena, G Ianiro, A Gasbarrini, M Pompili, F R Ponziani Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072–13088. doi: 10.26355/eurrev_202012_24215</mixed-citation><mixed-citation xml:lang="en">F Del Zompo 1, M De Siena, G Ianiro, A Gasbarrini, M Pompili, F R Ponziani Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072–13088. doi: 10.26355/eurrev_202012_24215</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Boggs W. Liver Injury Common With COVID-19. March 13, 2020 Available at: https://www.medscape.com/viewarticle/926628 ; Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. doi: 10.111</mixed-citation><mixed-citation xml:lang="en">Boggs W. Liver Injury Common With COVID-19. March 13, 2020 Available at: https://www.medscape.com/viewarticle/926628 ; Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. doi: 10.111</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jia B., Yu Z. J., Duan Z. F., et al. Hyperammonaemia induces hepatic injury with alteration of gene expression profi les. Liver Int. 2014 May;34(5):748–58. doi: 10.1111/liv.12365. Epub 2013 Nov 20. PMID: 24134218.</mixed-citation><mixed-citation xml:lang="en">Jia B., Yu Z. J., Duan Z. F., et al. Hyperammonaemia induces hepatic injury with alteration of gene expression profi les. Liver Int. 2014 May;34(5):748–58. doi: 10.1111/liv.12365. Epub 2013 Nov 20. PMID: 24134218.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Агеева E. А., Алексеенко С. А. Применение пероральной формы L-орнитин- L-аспартата (LOLA) при гипераммониемии у пациентов с хроническими заболеваниями печени на доцирротической стадии // Эффективная фармакотерапия. Гастроэнтерология. 2017. № 16. С. 6–8.</mixed-citation><mixed-citation xml:lang="en">Ageyeva Ye.A., Alekseyenko S. А. Use of Oral L-Ornithine- L-Aspartate (LOLA) in the Treatment of Hyperammonemia in Patients with Chronic Liver Disease in the Pre- Cirrhotic Stage. Effective Pharmacotherapy. 2017. Issue 16. Gastroenterology, pp. 6–8. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Богомолов П. О., Буеверов А. О., Уварова О. В., Мациевич М. В. Гипераммониемия у пациентов с заболеваниями печени на доцирротической стадии: возможно ли это? // Клин. перспективы гастроэнтерологии, гепатологии. 2013. № 5. С. 3–8.</mixed-citation><mixed-citation xml:lang="en">Bogomolov P.O., Bueverov A. O., Uvarova O. V., Matsievich M. V. Hyperammonemia in patients with pre-cirrhotic liver disease: is it possible? Clinical perspectives of gastroenterology, hepatology. 2013. No. 5, pp. 3–8. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник Л. Б., Голованова Е. В., Алексеенко С. А., и соавт. Российский консенсус «Гипераммониемии у взрослых». Экспериментальная и клиническая гастроэнтерология. 2019;(12):4–23. doi:10.31146/1682–8658-ecg-172–12–4–23</mixed-citation><mixed-citation xml:lang="en">Lazebnik L. B., Golovanova E. V., Alekseenko S. A., et al. Russian Consensus “Hyperammonemia in Adults”. Experimental and Clinical Gastroenterology. 2019;(12):4– 23. (In Russ.) doi: 10.31146/1682–8658-ecg-172–12–4–23</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Guan W. J. Clinical characteristics of coronavirus disease 2019 in China / W. J. Guan, Z. Y. Ni, Hu Y., et al. New England journal of medicine. 2020; 382: 18: 1708–1720.</mixed-citation><mixed-citation xml:lang="en">Guan W. J. Clinical characteristics of coronavirus disease 2019 in China / W. J. Guan, Z. Y. Ni, Hu Y., et al. New England journal of medicine. 2020; 382: 18: 1708–1720.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Han H. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. H. Han, L. Yang, R. Liu., et al. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 1–5.ahead-of-print (Accessed: 15.11.2020).</mixed-citation><mixed-citation xml:lang="en">Han H. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. H. Han, L. Yang, R. Liu., et al. Clinical Chemistry and Laboratory Medicine (CCLM). 2020; 1–5.ahead-of-print (Accessed: 15.11.2020).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И. Т. Взаимосвязь маркеров воспаления и морфофункционального состояния эритроцитов и тромбоцитов при новой коронавирусной болезни 2019 (COVID-19) / И. Т. Муркамилов // Вестник КРСУ. 2021. Т. 21. № 1. С. 43–52.</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.Т. the relationship between markers of inflammation and the morphofunctional state of erythrocytes and platelets in the new coronavirus disease 2019 (covid-19). Journal” Herald of KRSU”, 2021 year, Tom 21, no 1, p. 43–52. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Targher G., Mantovani A., Byrne C. D. et al. Risk of severe illness from COVID-19 in patients with metabolic dysfunction- associated fatty liver disease and increased fibrosis scores. Gut. 2020 Aug;69(8):1545–1547. doi: 10.1136/gutjnl-2020–321611. Epub 2020 May 15. PMID: 32414813.</mixed-citation><mixed-citation xml:lang="en">Targher G., Mantovani A., Byrne C. D. et al. Risk of severe illness from COVID-19 in patients with metabolic dysfunction- associated fatty liver disease and increased fibrosis scores. Gut. 2020 Aug;69(8):1545–1547. doi: 10.1136/gutjnl-2020–321611. Epub 2020 May 15. PMID: 32414813.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Prins G.H., Olinga P. Potential implications of COVID-19 in non-alcoholic fatty liver disease. Liver Int. 2020 Oct;40(10):2568. doi: 10.1111/liv.14484. Epub 2020 May 25. PMID: 32306495; PMCID: PMC7264616.</mixed-citation><mixed-citation xml:lang="en">Prins G.H., Olinga P. Potential implications of COVID-19 in non-alcoholic fatty liver disease. Liver Int. 2020 Oct;40(10):2568. doi: 10.1111/liv.14484. Epub 2020 May 25. PMID: 32306495; PMCID: PMC7264616.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
